BioVariance GmbH, founded in 2013 and headquartered in Tirschenreuth, Germany, is a bioinformatics company specializing in data-driven diagnostics. Their mission is to enhance patient health and quality of life through the interdisciplinary analysis and interpretation of medical data.

The company focuses on making biomedical variance quantifiable to actively utilize it in disease treatment. Their vision encompasses a world where complex diseases such as cancer, infectious, and neurodegenerative diseases are as easily treatable as the common cold.

BioVariance employs machine learning and mathematical algorithms to analyze complex biomedical data, offering long-term monitoring of molecular changes in patients. This approach aids in predicting the effectiveness, side effects, and drug interactions, thereby assisting in determining optimal medication and dosage